PaleoEvoMed Paleo-Evolutionary Medicine: Using ancient DNA to study the origins of common complex diseases
- Coordinator
- The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom
- Runs
- 1 December 2025 to 30 November 2030
- Status
- Running
- EU funding
- €1.4m
- Total cost
- €1.4m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101222614
What the project is doing
In the project's own words, from its summary on CORDIS.
Common diseases, such as cancer, dementia and heart disease, are the leading causes of death globally. In the UK, it is estimated that 1 in 2 people will develop cancer in their lifetime, 1 in 3 will develop dementia, and 1 in 4 will die from cardiovascular disease. However, the risks of developing common diseases are not shared equally between individuals or populations. Genetic susceptibility to disease is a major contributor to disease prevalence, alongside diet, lifestyle and other environmental factors.
Understanding the genetic component of disease risk is a critical issue in epidemiology, as it directly informs public health policy, disease prevention and the development of vaccines and novel therapeutics. Most of the existing research in this area has focused on the underlying genetics of risk, while relatively little is known about the evolutionary origins of common diseases. This is a major omission, as understanding the origins of genetic risk can improve health outcomes in the present.
In this ERC Starting Grant, I will use ancient DNA to model the evolutionary origins of genetic susceptibility to the leading causes of death and ill health worldwide, including cancer, dementia, cardiovascular, metabolic, autoimmune, respiratory and infectious diseases. I will build and apply state-of-the-art computational tools to (i) model the effects of natural selection on disease risk in the human genome; to (ii) reconstruct the evolutionary history of human and zoonotic pathogens; and to (iii) model the effects of pathogens, and other environmental factors, on the evolution of human disease susceptibility.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI